New York State Common Retirement Fund Regeneron Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $68.1 Billion
- Q1 2025
A detailed history of New York State Common Retirement Fund transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 130,540 shares of REGN stock, worth $77.3 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
130,540
Previous 137,386
4.98%
Holding current value
$77.3 Million
Previous $97.9 Million
15.4%
% of portfolio
0.12%
Previous 0.13%
Shares
30 transactions
Others Institutions Holding REGN
# of Institutions
1,470Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.57 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.35 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.83 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.36 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $63.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...